Hologic Inc. [NASDAQ: HOLX] surged by $1.78 during the normal trading session on Thursday and reaching a high of $71.91 during the day while it closed the day at $71.89. The company report on July 13, 2022 that Hologic Showcases Advances across the Continuum of Breast Health at ECR 2022.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
–Global Leader in Women’s Health Highlights Importance of Timely and Accurate Diagnosis–.
Hologic, Inc. (Nasdaq: HOLX) will showcase their comprehensive portfolio of breast and skeletal health solutions at the annual European Congress of Radiology (ECR) in Vienna, Austria from July 13-17.
Hologic Inc. stock has also gained 3.60% of its value over the past 7 days. However, HOLX stock has declined by -8.05% in the 3 months of the year. Over the past six months meanwhile, it has gained 2.09% and lost -6.10% year-on date.
The market cap for HOLX stock reached $17.62 billion, with 251.57 million shares outstanding and 247.60 million shares in the current float. Compared to the average trading volume of 1.98M shares, HOLX reached a trading volume of 2164603 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Hologic Inc. [HOLX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HOLX shares is $79.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HOLX stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for Hologic Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on July 20, 2022. While these analysts kept the previous recommendation, BofA Securities dropped their target price from $81 to $75. The new note on the price target was released on July 20, 2022, representing the official price target for Hologic Inc. stock.
The Average True Range (ATR) for Hologic Inc. is set at 1.81, with the Price to Sales ratio for HOLX stock in the period of the last 12 months amounting to 3.27. The Price to Book ratio for the last quarter was 3.77, with the Price to Cash per share for the same quarter was set at 9.34. Price to Free Cash Flow for HOLX in the course of the last twelve months was 6.55 with Quick ratio for the last quarter at 2.60.
HOLX stock trade performance evaluation
Hologic Inc. [HOLX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.60. With this latest performance, HOLX shares gained by 5.41% in over the last four-week period, additionally plugging by 2.09% over the last 6 months – not to mention a rise of 2.70% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HOLX stock in for the last two-week period is set at 53.63, with the RSI for the last a single of trading hit 57.87, and the three-weeks RSI is set at 51.20 for Hologic Inc. [HOLX]. The present Moving Average for the last 50 days of trading for this stock 72.68, while it was recorded at 70.31 for the last single week of trading, and 73.05 for the last 200 days.
Hologic Inc. [HOLX]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Hologic Inc. [HOLX] shares currently have an operating margin of +44.08 and a Gross Margin at +66.64. Hologic Inc.’s Net Margin is presently recorded at +33.23.
Return on Total Capital for HOLX is now 37.57, given the latest momentum, and Return on Invested Capital for the company is 29.89. Return on Equity for this stock inclined to 54.06, with Return on Assets sitting at 23.23. When it comes to the capital structure of this company, Hologic Inc. [HOLX] has a Total Debt to Total Equity ratio set at 74.54. Additionally, HOLX Total Debt to Total Capital is recorded at 42.71, with Total Debt to Total Assets ending up at 35.25. Long-Term Debt to Equity for the company is recorded at 66.40, with the Long-Term Debt to Total Capital now at 38.04.
Reflecting on the efficiency of the workforce at the company, Hologic Inc. [HOLX] managed to generate an average of $279,120 per employee. Receivables Turnover for the company is 4.74 with a Total Asset Turnover recorded at a value of 0.70.Hologic Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.60 and a Current Ratio set at 3.00.
Earnings per share (EPS) analysis for Hologic Inc. [HOLX] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HOLX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Hologic Inc. go to 1.70%.
Hologic Inc. [HOLX]: Insider Ownership positions
There are presently around $16,351 million, or 98.18% of HOLX stock, in the hands of institutional investors. The top three institutional holders of HOLX stocks are: PRICE T ROWE ASSOCIATES INC /MD/ with ownership of 43,106,780, which is approximately 4.383% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 27,882,301 shares of the stock with an approximate value of $1.95 billion in HOLX stocks shares; and BLACKROCK INC., currently with $1.53 billion in HOLX stock with ownership of nearly -0.339% of the company’s market capitalization.
Positions in Hologic Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 363 institutional holders increased their position in Hologic Inc. [NASDAQ:HOLX] by around 18,396,857 shares. Additionally, 310 investors decreased positions by around 17,116,569 shares, while 99 investors held positions by with 197,702,073 shares. The mentioned changes placed institutional holdings at 233,215,499 shares, according to the latest SEC report filing. HOLX stock had 89 new institutional investments in for a total of 3,704,319 shares, while 79 institutional investors sold positions of 4,381,785 shares during the same period.